Saint Xiang Biological: Net profit in the first half of 2025 was 163 million yuan, a year-on-year increase of 3.84%.

Shengxiang Bioscience announced that in the first half of 2025, the operating income was 869 million yuan, an increase of 21.15% year-on-year. The net profit was 163 million yuan, an increase of 3.84% year-on-year. The company plans to distribute cash dividends of 2.62 yuan for every 10 shares to all shareholders, based on the total share capital registered on the equity distribution date minus the shares held in the company's repurchase special securities account, without increasing capital reserves or issuing bonus shares.